You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 557 Determining the efficacy of ADCC by the 3D-EX ex vivo platform utilizing tumoroids of fresh patient tumor samples with intact tumor microenvironment

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
557 Determining the efficacy of ADCC by the 3D-EX ex vivo platform utilizing tumoroids of fresh patient tumor samples with intact tumor microenvironment

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 202098014
Dec 20201804
Jan 20212003
Feb 20211604
Mar 20212603
Apr 20211002
May 2021604
Jun 2021004
Jul 2021003
Aug 2021004
Sep 2021004
Oct 20210021
Nov 20218016
Dec 2021801
Jan 2022800
Feb 20221601
Mar 20221803
Apr 20223601
May 20221200
Jun 20221800
Jul 20221401
Aug 20221003
Sep 20221000
Oct 20221002
Nov 2022802
Dec 20221002
Jan 2023600
Feb 20231200
Mar 20231602
Apr 2023201
May 2023401
Jun 2023200
Jul 20231202
Aug 20231202
Sep 2023403
Oct 2023801
Nov 20231401
Dec 20232800
Jan 20241600
Feb 20242000
Mar 20242400
Apr 2024802
May 20242000
Jun 20242201
Jul 20241600
Aug 20241801
Sep 20242803
Oct 20242005
Nov 20241204
Dec 20241206
Jan 20251406
Feb 2025401
Mar 20252010
Apr 2025002
May 2025005
Jun 2025003
Total7360164